Skip to main content
. 2023 Sep 5;12(10):e230075. doi: 10.57264/cer-2023-0075

Figure 2. . Cost-effectiveness acceptability curve showing the likelihood of real-time continuous glucose monitoring being cost-effective versus self-monitoring of blood glucose over a range of willingness-to-pay thresholds.

Figure 2.